Rennova Health (RNVA) has a profit margin of -41.36%, below the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2023
Trailing 12 months ending Dec 2023
The latest profit margin for RNVA is -41.36% as of December 2023. That compares with -25.26% in the prior-year period — down 63.7% year over year. That is below the sector sector average of 13.4%. Investors often review this figure alongside Rennova Health's historical trend and sector peers before judging valuation or financial health.
Over the past year, RNVA's profit margin moved from -25.26% to -41.36% — a 63.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Rennova Health's valuation or profitability profile.
Against its sector companies, RNVA currently prints -41.36% for profit margin, while the sector average sits near 13.4%. That is roughly 408.6% below the sector mean. Large gaps often invite a closer look at Rennova Health's growth, margins, and balance sheet.
Profit Margin shows how effectively Rennova Health converts resources into returns. At -41.36%, RNVA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -25.26% in the prior-year period — down 63.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting RNVA's profit margin (-41.36%), review year-over-year change from -25.26%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.